Autopsy report · NCT00938119

Care China-Diabetes

“the product was delisted.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 4 months before it stopped.
• 1,603 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Johnson & Johnson Medical, China

Sponsor type

Industry

Conditions

Cardiovascular Disease; Diabetes

Participants

1,603

Sites

46

Countries

China

Trials that died the same way

• Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System
  “Product is no longer being manufactured and marketed.” (66% match in meaning)
• The Study for Evaluate of Satety and Dfficacy of Hemostatic Device
  “The company stopped manufacturing the product” (65% match in meaning)
• Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
  “Sponsor discontinued the study following the discovery of a number of incompletely sealed batches that were unusable.” (60% match in meaning)
• Stomaplasty Ring (KoringTM) for Prevention of Parastomal Hernia
  “The device used was removed from the market” (60% match in meaning)
• Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
  “Product no longer on the market” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.